Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 16.67% vs 45.45% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -25.00% vs 87.50% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Arch Biopartners, Inc. With
Quarterly - Net Sales
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 68.75% vs -433.33% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 16.67% vs 45.45% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 66.67% vs -650.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -25.00% vs 87.50% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025






